Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eli Lilly & Co. Global External R&D-Asia VP Tony Zhang On Lilly's FIPNET Strategies In China

This article was originally published in The Pink Sheet Daily

Executive Summary

Zhang discusses Lilly's strategies in an interview with PharmAsia News' Shanghai bureau editors.

You may also be interested in...

Lilly Shifts Gears In China With New Shanghai-based R&D Center

Eli Lilly is deepening its commitment to China and diabetics in the country by opening a new R&D center in Shanghai that aims to discover novel compounds that will lead to breakthrough therapies for diabetes

Lilly Closes Its Singapore Drug Discovery Center; Is China Discovery Unit In The Works?

Eli Lilly announced Oct. 18 that it will shut the doors of its eight-year-old Lilly Singapore Center for Drug Discovery

Lilly Snatches ImClone Away From Bristol

Lilly’s $6.5 billion acquisition of ImClone will create an oncology “powerhouse” with 18 cancer drugs in clinical development.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts